Glucotrack (GCTK) Stock: Why It's Down Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.68, -5.56% vs the prior close of $0.73.
- Volume 79.19K shares, 0.0x its 50-day average (light).
- New SEC filings: 8-K (Oct 19, 2026).
- No new insider buys or sales reported since the prior session.
GCTK slides 5.6% to $0.68, a 52-week low, 5 down days in a row. Closed at $0.68, -5.56% vs the prior close of $0.73. Day range $0.68–$0.73, opened at $0.73.
GCTK daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — GCTK slides 5.6% to $0.68, a 52-week low, 5 down days in a row
- Closed at $0.68, -5.56% vs the prior close of $0.73. Day range $0.68–$0.73, opened at $0.73.
- Volume was 79.19K shares, 0.0x its 50-day average of 1.82M — lighter than usual.
- Price is -77.0% vs its 50-day average ($2.97) and -95.2% vs its 200-day average ($14.22).
- 52-week range $0.68–$112.50; today's close sits at 0% of that range, 99.4% below the 52-week high.
- That makes 5 straight losses.
Oct 16, 2026 — GCTK slides 12.9% to $0.73, a 52-week low, 4 down days in a row
- Closed at $0.73, -12.86% vs the prior close of $0.83. Day range $0.70–$0.84, opened at $0.84.
- Volume was 143.68K shares, 0.1x its 50-day average of 1.82M — lighter than usual.
- Price is -76.5% vs its 50-day average ($3.09) and -95.0% vs its 200-day average ($14.51).
- 52-week range $0.70–$112.50; today's close sits at 0% of that range, 99.4% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — GCTK slides 6.2% to $0.83, a 52-week low, 3 down days in a row
- Closed at $0.83, -6.20% vs the prior close of $0.89. Day range $0.76–$0.88, opened at $0.88.
- Volume was 153.80K shares, 0.1x its 50-day average of 1.82M — lighter than usual.
- Price is -74.1% vs its 50-day average ($3.22) and -94.4% vs its 200-day average ($14.76).
- 52-week range $0.76–$112.50; today's close sits at 0% of that range, 99.3% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — GCTK slides 20.1% to $0.89, a 52-week low
- Closed at $0.89, -20.09% vs the prior close of $1.11. Day range $0.86–$1.10, opened at $1.10.
- Volume was 354.30K shares, 0.2x its 50-day average of 1.89M — lighter than usual.
- Price is -73.6% vs its 50-day average ($3.36) and -94.1% vs its 200-day average ($15.05).
- 52-week range $0.86–$112.50; today's close sits at 0% of that range, 99.2% below the 52-week high.
Oct 13, 2026 — GCTK slides 4.3% to $1.11
- Closed at $1.11, -4.31% vs the prior close of $1.16. Day range $1.07–$1.16, opened at $1.16.
- Volume was 162.10K shares, 0.1x its 50-day average of 1.89M — lighter than usual.
- Price is -68.5% vs its 50-day average ($3.52) and -92.8% vs its 200-day average ($15.36).
- 52-week range $1.00–$119.70; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 12, 2026 — GCTK jumps 12.6% to $1.16
- Closed at $1.16, +12.62% vs the prior close of $1.03. Day range $1.04–$1.20, opened at $1.09.
- Volume was 315.70K shares, 0.2x its 50-day average of 1.91M — lighter than usual.
- Price is -68.0% vs its 50-day average ($3.62) and -92.6% vs its 200-day average ($15.69).
- 52-week range $1.00–$123.75; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 9, 2026 — GCTK slides 7.2% to $1.03, a 52-week low
- Closed at $1.03, -7.21% vs the prior close of $1.11. Day range $1.00–$1.12, opened at $1.12.
- Volume was 235.80K shares, 0.1x its 50-day average of 2.40M — lighter than usual.
- Price is -72.5% vs its 50-day average ($3.74) and -93.6% vs its 200-day average ($16.02).
- 52-week range $1.00–$125.25; today's close sits at 0% of that range, 99.2% below the 52-week high.
Oct 8, 2026 — GCTK slides 3.5% to $1.11
- Closed at $1.11, -3.48% vs the prior close of $1.15. Day range $1.08–$1.21, opened at $1.12.
- Volume was 208.60K shares, 0.1x its 50-day average of 2.42M — lighter than usual.
- Price is -71.9% vs its 50-day average ($3.95) and -93.2% vs its 200-day average ($16.36).
- 52-week range $1.07–$136.29; today's close sits at 0% of that range, 99.2% below the 52-week high.
Oct 7, 2026 — GCTK rises 1.8% to $1.15
- Closed at $1.15, +1.77% vs the prior close of $1.13. Day range $1.10–$1.16, opened at $1.12.
- Volume was 97.20K shares, 0.0x its 50-day average of 2.42M — lighter than usual.
- Price is -71.4% vs its 50-day average ($4.02) and -93.1% vs its 200-day average ($16.71).
- 52-week range $1.07–$136.29; today's close sits at 0% of that range, 99.2% below the 52-week high.
Oct 6, 2026 — GCTK rises 1.8% to $1.13
- Closed at $1.13, +1.80% vs the prior close of $1.11. Day range $1.07–$1.14, opened at $1.12.
- Volume was 168.00K shares, 0.1x its 50-day average of 2.42M — lighter than usual.
- Price is -72.3% vs its 50-day average ($4.09) and -93.4% vs its 200-day average ($17.06).
- 52-week range $1.07–$136.29; today's close sits at 0% of that range, 99.2% below the 52-week high.
Oct 5, 2026 — GCTK slides 8.3% to $1.11, a 52-week low, 7 down days in a row
- Closed at $1.11, -8.26% vs the prior close of $1.21. Day range $1.09–$1.20, opened at $1.16.
- Volume was 232.80K shares, 0.1x its 50-day average of 2.42M — lighter than usual.
- Price is -73.3% vs its 50-day average ($4.15) and -93.6% vs its 200-day average ($17.41).
- 52-week range $1.09–$136.29; today's close sits at 0% of that range, 99.2% below the 52-week high.
- That makes 7 straight losses.
Oct 2, 2026 — GCTK slides 14.2% to $1.21, a 52-week low, 6 down days in a row
- Closed at $1.21, -14.18% vs the prior close of $1.41. Day range $1.15–$1.34, opened at $1.34.
- Volume was 293.20K shares, 0.1x its 50-day average of 2.41M — lighter than usual.
- Price is -71.3% vs its 50-day average ($4.22) and -93.2% vs its 200-day average ($17.79).
- 52-week range $1.15–$136.29; today's close sits at 0% of that range, 99.1% below the 52-week high.
- That makes 6 straight losses.
GCTK bull case vs bear case (from the data)
- Annual revenue grew 378.3% in the latest fiscal year (SEC XBRL).
- Price is -77.0% vs its 50-day average — short-term trend is down.
- Price is -95.2% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $19.39M.
- Share count up 1076.2% in a year (dilution).
- High volatility: average daily move of 9.6% over 20 sessions.
GCTK latest news & SEC filings
Every SEC filing by or about GCTK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Oct 14, 2026 · Form S-1/A — S-1/A filing
S-1/A filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 13, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Oct 13, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Exhibits / financial statements only (Item 9.01).
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 24, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 18, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 5.07 — Reported shareholder vote results.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
Things to know before you trade GCTK
- Last results release: May 14, 2026 (8-K Item 2.02). Previous ones: Mar 30, 2026, Nov 13, 2025, Aug 14, 2025. Based on that rhythm, the next report is likely around Aug 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 9.56% (largest 29.5%). That is a volatile stock.
- Liquidity: about 4.34M shares (≈$2.97M) trade per day on average.
- 52-week position: $0.68 vs a range of $0.68–$112.50 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:15 on Aug 31, 2026, 1:60 on Jun 16, 2025, 1:20 on Feb 4, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 19, 2026; 8-K Sep 28, 2026; 8-K Sep 24, 2026.
- Share count: 10.58M shares outstanding (Aug 14, 2026), +1076.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
GCTK market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.73 | 0.73 | 0.68 | 0.68 | 79.19K |
| Oct 16, 2026 | 0.84 | 0.84 | 0.70 | 0.73 | 144.40K |
| Oct 15, 2026 | 0.88 | 0.88 | 0.76 | 0.83 | 153.80K |
| Oct 14, 2026 | 1.10 | 1.10 | 0.86 | 0.89 | 354.30K |
| Oct 13, 2026 | 1.16 | 1.16 | 1.07 | 1.11 | 162.10K |
| Oct 12, 2026 | 1.09 | 1.20 | 1.04 | 1.16 | 315.70K |
| Oct 9, 2026 | 1.12 | 1.12 | 1.00 | 1.03 | 235.80K |
| Oct 8, 2026 | 1.12 | 1.21 | 1.08 | 1.11 | 208.60K |
| Oct 7, 2026 | 1.12 | 1.16 | 1.10 | 1.15 | 97.20K |
| Oct 6, 2026 | 1.12 | 1.14 | 1.07 | 1.13 | 168.00K |
| Oct 5, 2026 | 1.16 | 1.20 | 1.09 | 1.11 | 232.80K |
| Oct 2, 2026 | 1.34 | 1.34 | 1.15 | 1.21 | 293.20K |
| Oct 1, 2026 | 1.64 | 1.64 | 1.38 | 1.41 | 634.10K |
| Sep 30, 2026 | 1.79 | 1.82 | 1.51 | 1.64 | 1.17M |
| Sep 29, 2026 | 1.72 | 1.85 | 1.57 | 1.74 | 264.80K |
| Sep 28, 2026 | 1.84 | 1.95 | 1.78 | 1.80 | 519.70K |
| Sep 25, 2026 | 2.31 | 2.36 | 1.77 | 1.82 | 2.02M |
| Sep 24, 2026 | 2.43 | 3.25 | 2.38 | 2.58 | 51.60M |
| Sep 23, 2026 | 2.23 | 2.27 | 2.00 | 2.03 | 27.58M |
| Sep 22, 2026 | 2.22 | 2.31 | 2.21 | 2.22 | 540.00K |
About Glucotrack
Glucotrack (GCTK) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in RUTHERFORD, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1506983.
GCTK board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Andrew K Balo | Director | Oct 7, 2025 |
| Brendel Victoria Carr | Director | Oct 7, 2025 |
| Erin Catherine Carter | Director | Oct 7, 2025 |
| Paul Goode | Chief Executive Officer | Oct 7, 2025 |
| Luis Malave | Director | Oct 7, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paul Goode | Chief Executive Officer | Oct 7, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
GCTK financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-19.39M | 31.22 | $-15.24M |
| Dec 31, 2024 | — | $-22.60M | 4,106.00 | $-12.49M |
| Dec 31, 2023 | — | $-7.10M | 34.18 | $-6.56M |
| Dec 31, 2022 | — | $-4.43M | 0.29 | $-3.73M |
| Dec 31, 2021 | — | $-4.07M | 0.26 | $-3.77M |
Latest balance sheet: total assets $1.50M, total liabilities $3.24M, cash $1.12M (as of Jun 30, 2026).
GCTK earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 14, 2026 | 8-K Item 2.02 (results) | $10.05 |
| Mar 30, 2026 | 8-K Item 2.02 (results) | $11.35 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $85.05 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $85.80 |
| May 14, 2025 | 8-K Item 2.02 (results) | $135.00 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $157.50 |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Tesla (TSLA)Space Exploration Technologies (SPCX)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on GCTK
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.